CRISPR Therapeutics AG (NASDAQ:CRSP) concluded the trading at $34.19 on Wednesday, April 03 with a rise of 3.17% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $33.14 and 5Y monthly beta
CRISPR Therapeutics AG (NASDAQ:CRSP) traded at $33.80 at last check on current trade day and made a downward move of -8.62% on its previous day’s price. Looking at the stock we see that its previous close was $36.99 and the beta (5Y monthly) reads 1.762
CRISPR Therapeutics AG (NASDAQ:CRSP) shares, rose in value, with the stock price down by -0.75% to the previous day’s close as strong demand from buyers drove the stock to $38.88. Actively observing the price movement in the recent trading, the stock is buoying the session
The trading price of CRISPR Therapeutics AG (NASDAQ:CRSP) closed higher on current market day and closing at $42.62, 3.40% higher than its previous close. Traders who pay close attention to intraday price movement should know that it fluctuated between $41.88 and $42.72. In examining the
CRISPR Therapeutics AG (NASDAQ:CRSP) price on Thursday, March 20, fall -1.84% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $41.17. A look at the stock’s price movement, the close in the last trading session was $41.94, moving
CRISPR Therapeutics AG (NASDAQ:CRSP) price closed higher on Monday, March 17, and jumping 1.66% above its previous close. A look at the daily price movement shows that the last close reads $42.12, with intraday deals fluctuated between $41.455 and $43.32. The company’s 5Y monthly beta
CRISPR Therapeutics AG (NASDAQ:CRSP) concluded the trading at $41.99 on Thursday, March 13 with a fall of -3.45% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $43.49 and 5Y monthly beta
CRISPR Therapeutics AG (NASDAQ:CRSP) traded at $42.94 at last check on current trade day and made a downward move of -5.68% on its previous day’s price. The median projection represents growth squeezing down to 1,162.84% compared to sales growth for the corresponding quarter a year
CRISPR Therapeutics AG (NASDAQ:CRSP) shares, rose in value on Thursday, March 06, with the stock price down by -1.21% to the previous day’s close as strong demand from buyers drove the stock to $43.31. Actively observing the price movement in the last trading, the stock
The trading price of CRISPR Therapeutics AG (NASDAQ:CRSP) closed higher on Friday, February 28, and closing at $43.92, 0.69% higher than its previous close. In examining the 52-week price action we see that the stock hit a 52-week high of $90.62 and a 52-week low
Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.
